US Patent 10245275 Triterpenoids with HIV maturation inhibitory activity
Patent 10245275 was granted and assigned to ViiV Healthcare on April, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+287 characters)
Article
Patent abstract
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, triterpenoids that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I:
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Alicia Regueiro-Ren0
Brian Lee Venables0
Jacob Swidorski0
Jie Chen0
Li Xu0
Nicholas A. Meanwell0
Ny Sin0
Richard A. Hartz0
Sing-Yuen Sit0
Yan Chen0
Zheng Liu0
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
102452750
Date of Patent
April 2, 2019
0Patent Application Number
156783810
Date Filed
August 16, 2017
0Patent Primary Examiner
Edits on 25 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10245275 Triterpenoids with HIV maturation inhibitory activity
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10245275
Date of patent
April 2, 2019
Patent application number
15678381
Date Filed
August 16, 2017
Patent primary examiner
Find more entities like US Patent 10245275 Triterpenoids with HIV maturation inhibitory activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.